JESSICA COSENZA: Open Payments
NPI 1992895189 · WORCESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$615 in 27 payments from 7 companies in 2025. Trend: 2023 $200 · 2024 $107 · 2025 $615
Food & beverage: $421Education: $194
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $191 |
| ABBVIE INC. | 10 | $142 |
| Galderma Laboratories, L.P. | 5 | $101 |
| SANOFI-AVENTIS U.S. LLC | 1 | $95 |
| Organon LLC | 1 | $32 |
| GENZYME CORPORATION | 1 | $30 |
| Incyte Corporation | 1 | $23 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, NEMLUVIO, RINVOQ, HADLIMA, OPZELURA, AKLIEF.
Industry payments across MA — which companies pay providers there.
